D. Western Therapeutics Institute, Inc. (FRA:6DW)

FRA:6DW Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	31	51	29	57	48	67
Market Cap Growth	102.43%	73.82%	-48.77%	17.18%	-27.68%	-52.11%
Enterprise Value	25	50	21	48	37	52
Last Close Price	0.55	1.12	0.81	1.75	1.55	1.97
PS Ratio	13.03	17.47	10.58	17.85	15.32	23.81
PB Ratio	3.73	11.22	3.54	4.28	3.12	3.91
P/TBV Ratio	3.77	11.94	3.80	4.62	3.45	4.32
EV/Sales Ratio	10.83	17.25	7.76	15.08	11.55	18.43
Debt / Equity Ratio	0.35	1.09	0.69	0.52	0.17	0.21
Asset Turnover	0.19	0.23	0.16	0.17	0.16	0.15
Inventory Turnover	0.42	0.50	0.43	0.34	0.29	0.29
Quick Ratio	8.16	9.48	10.23	11.87	10.54	11.48
Current Ratio	9.15	11.17	11.02	12.60	11.20	11.98
Return on Equity (ROE)	-85.00%	-128.23%	-52.51%	-22.59%	-7.62%	-16.30%
Return on Assets (ROA)	-29.73%	-37.42%	-18.72%	-7.06%	-4.13%	-7.05%
Return on Capital (ROIC)	-32.01%	-40.96%	-19.95%	-7.34%	-4.30%	-7.37%
Return on Capital Employed (ROCE)	-53.10%	-78.70%	-36.60%	-11.10%	-7.60%	-10.50%
Earnings Yield	-19.30%	-15.68%	-17.93%	-5.36%	-2.33%	-3.26%
FCF Yield	-	-15.90%	-13.20%	-4.54%	-2.81%	-2.61%
Buyback Yield / Dilution	-33.08%	-10.51%	-7.22%	-1.04%	-7.96%	-3.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.